fda compounding semaglutide crackdown 2025 news Troubling Findings in Study of GLP-1 Compounders 🚨 FDA Moves to Permanently

As convenient as thatd be, theres currently a strong lack of human clinical research for these peptides

Initially, they had planned to continue the study for a further year, but because of the lack of positive results, they cancelled the extension

Fluid retention in the digestive tract: Temporary fluid buildup in the digestive system can create abdominal swelling and contribute to the sensation of bloating (NIH)

How It's Different: Unlike traditional ED medications like Viagra, PT-141 targets the central nervous system to create natural sexual desire, making it effective for both men and women

In clinical trials, hair loss was reported in 3-5% of patients using GLP-1 medications compared to just 1% using placebo